Search details
1.
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma.
Blood
; 140(12): 1378-1389, 2022 09 22.
Article
in English
| MEDLINE | ID: mdl-35737911
2.
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients.
Clin Infect Dis
; 77(2): 280-286, 2023 07 26.
Article
in English
| MEDLINE | ID: mdl-36976301
3.
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
Br J Haematol
; 201(4): 628-639, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36806152
4.
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
Hematol Oncol
; 41(4): 655-662, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37246287
5.
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study.
Haematologica
; 107(7): 1633-1642, 2022 07 01.
Article
in English
| MEDLINE | ID: mdl-34407602
6.
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi.
Ann Hematol
; 100(10): 2547-2556, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34327561
7.
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
Ann Hematol
; 93(12): 2011-8, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-24989345
8.
Early CAR- CD4+ T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma.
EJHaem
; 5(2): 360-368, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38633118
9.
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Blood Adv
; 8(6): 1541-1549, 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38181782
10.
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".
Ann Hematol
; 92(10): 1309-18, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23686116
11.
Brain FDG-PET findings in chimeric antigen receptor T-cell therapy neurotoxicity for diffuse large B-cell lymphoma.
J Neuroimaging
; 33(5): 825-836, 2023.
Article
in English
| MEDLINE | ID: mdl-37291470
12.
Divergent Oxidative Stress in Normal Tissues and Inflammatory Cells in Hodgkin and Non-Hodgkin Lymphoma.
Cancers (Basel)
; 15(13)2023 Jul 07.
Article
in English
| MEDLINE | ID: mdl-37444643
13.
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL.
Blood Adv
; 7(15): 3916-3924, 2023 08 08.
Article
in English
| MEDLINE | ID: mdl-37171620
14.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Leukemia
; 37(2): 433-440, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36653509
15.
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.
Blood Adv
; 7(16): 4435-4447, 2023 08 22.
Article
in English
| MEDLINE | ID: mdl-37276067
16.
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia.
Haematologica
; 102(9): e348-e351, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28495917
17.
Laparoscopic lymph node biopsy for lymphoma with a novel use of indocyanine green fluorescence in a 66-year-old male patient.
Int J Surg Case Rep
; 90: 106692, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34952317
18.
Safety of the Anti-CD19 antibody Tafasitamab in Long Term Responders from A Phase II Trial for Relapsed Lymphoma.
Clin Lymphoma Myeloma Leuk
; 22(4): 270-275, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34776401
19.
CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma.
Front Immunol
; 13: 837457, 2022.
Article
in English
| MEDLINE | ID: mdl-35280988
20.
Mitochondrial Generated Redox Stress Differently Affects the Endoplasmic Reticulum of Circulating Lymphocytes and Monocytes in Treatment-Naïve Hodgkin's Lymphoma.
Antioxidants (Basel)
; 11(4)2022 Apr 11.
Article
in English
| MEDLINE | ID: mdl-35453447